Role of a genetic marker in ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at a molecule called CircDENND4C in women newly diagnosed with ovarian cancer who have not yet had surgery or any cancer treatment. It aims to understand how this molecule might be linked to the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with ovarian cancer at South Egypt Cancer Institute.
- You have not had surgery for your cancer yet.
- You have not received any anti-cancer therapy (like chemotherapy or radiation).
- You do not have any other cancer or chronic disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain substances in the body (called metabolic biomarkers) and how they relate to how well patients do after treatment. It is for women who have just been diagnosed with high-grade serous ovarian cancer and have not yet had any treatment.
This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study uses a custom lab test on blood (and tumor tissue) to track ovarian cancer returning and to see how well treatment is working. It may help your care team monitor changes over time, especially after certain surgeries.
This study collects a blood sample before you have surgery or a biopsy for an ovarian mass. Researchers will test whether a new blood test can accurately identify ovarian cancer by looking at DNA patterns in your blood. The results will help doctors understand if this blood test could help detect ovarian cancer earlier in the future.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.